{
    "2019-06-28": [
        [
            {
                "time": "2019-03-15",
                "original_text": "How Eli Lilly’s EPS and Expenses Are Trending",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "EPS",
                        "Expenses",
                        "Trending"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-20",
                "original_text": "How Is Eli Lilly’s Revenue Trending in 2019?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Revenue",
                        "Trending",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "What Analysts Recommend for LLY and AMGN",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "LLY",
                        "AMGN"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell, CELG's Otezla to Close Merger",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "ABBV",
                        "AGN",
                        "BMY",
                        "CELG",
                        "Otezla",
                        "Merger"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}